Please use this identifier to cite or link to this item: http://hdl.handle.net/11452/14516
Full metadata record
DC FieldValueLanguage
dc.contributor.authorYenilmez, Kudret-
dc.contributor.authorEren, Nihal-
dc.date.accessioned2020-12-21T12:35:10Z-
dc.date.available2020-12-21T12:35:10Z-
dc.date.issued2019-04-14-
dc.identifier.citationYenilmez, K. ve Eren, N. (2019). "The utilization areas of cabergoline in veterinary gynecology". Bursa Uludağ Üniversitesi Veteriner Fakültesi, 38(1), 77-81.tr_TR
dc.identifier.issn1301-3173-
dc.identifier.urihttps://dergipark.org.tr/tr/download/article-file/764369-
dc.identifier.urihttp://hdl.handle.net/11452/14516-
dc.description.abstractCabergoline is a potent dopamine agonist and a synthetic ergot derivative, and it acts by inhibiting prolactin secretion from the pituitary gland. It reduces the amount of plasma prolactin and inhibits progesterone secretion at the same time. Because of these effects, it has found a widespread area of use in the treatment of hyperprolactinemic disorders both in the human medicine and veterinary medicine.en_US
dc.language.isoenen_US
dc.publisherBursa Uludağ Üniversitesitr_TR
dc.rightsinfo:eu-repo/semantics/openAccesstr_TR
dc.rightsAtıf 4.0 Uluslararasıtr_TR
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.subjectCabergolineen_US
dc.subjectVeterinaryen_US
dc.subjectGynaecologyen_US
dc.titleThe utilization areas of cabergoline in veterinary gynecologyen_US
dc.typeArticleen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergitr_TR
dc.identifier.startpage77tr_TR
dc.identifier.endpage81tr_TR
dc.identifier.volume38tr_TR
dc.identifier.issue1tr_TR
dc.relation.journalVeteriner Hekimlikte Araştırma Dergisi / Journal of Research in Veterinary Medicinetr_TR
Appears in Collections:2019 Cilt 38 Sayı 1

Files in This Item:
File Description SizeFormat 
38_1_11.pdf130.02 kBAdobe PDFThumbnail
View/Open


This item is licensed under a Creative Commons License Creative Commons